Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/29/2007DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators
11/29/2007DE102006024834A1 Neue Indol-Pyrrol-Derivate und deren Verwendung New indole-pyrrole derivatives and their use
11/29/2007DE102006024528A1 Neue, an der Tumorphysiologie orientierte Formulierung eines Zytostatikums, insbesondere von cis-Platin Last, based on the formulation of a cytostatic tumor physiology, in particular cis-platinum
11/29/2007CA2688206A1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
11/29/2007CA2653117A1 Substituted pteridines substituted with a four-membered heterocycle
11/29/2007CA2653085A1 Aqueous solution of 20(r)-ginsenoside rg3 pharmaceutical composition and process thereof
11/29/2007CA2652886A1 High affinity human and humanized anti-.alpha.5.beta.1 integrin function blocking antibodies with reduced immunogenicity
11/29/2007CA2652870A1 Treatment of cancer with anti-il-1a antibodies
11/29/2007CA2652840A1 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases
11/29/2007CA2652758A1 Reversion of malignant phenotype with 9-hydroxy ellipticine derivatives
11/29/2007CA2652689A1 Method of constructing gene transport support
11/29/2007CA2652656A1 High-molecular weight conjugate of podophyllotoxins
11/29/2007CA2652634A1 Certain substituted quinolones, compositions, and uses thereof
11/29/2007CA2652617A1 Flavonoid dimers and methods of making and using such
11/29/2007CA2652590A1 Ruthenium ii compounds
11/29/2007CA2652442A1 Antitumor agent for thyroid cancer
11/29/2007CA2652399A1 Novel compounds
11/29/2007CA2652394A1 Triazole derivatives ii
11/29/2007CA2652393A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007CA2652365A1 Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
11/29/2007CA2651763A1 Magnetorheological fluids and therapeutic uses thereof
11/29/2007CA2651411A1 39-desmethoxy-39-methyl derivatives of rapamycin
11/29/2007CA2651405A1 36 -des (3 -methoxy-4 -hydroxycyclohexyl) 36 - (3 -hydroxycycloheptyl) derivatives of rapamycin for the treatment of cancer and other disorders
11/29/2007CA2650916A1 Crystalline forms of 5-chloro-6-(2,6-difluoro-4-[3-(methylamino)propoxy]phenyl)-n-[(1s)-2,2,2-trifluoro-1-methylethyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine salts
11/29/2007CA2650611A1 Compositions and methods for fgf receptor kinases inhibitors
11/29/2007CA2649685A1 Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation et utilisation connexes, et compositions contenant lesdits derives
11/29/2007CA2649336A1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/29/2007CA2637988A1 Anti-fgf19 antibodies and methods using same
11/28/2007EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007EP1860187A1 Apo-2 receptor
11/28/2007EP1860119A1 ANTI-IgSF4 ANTIBODY AND UTILIZATION OF THE SAME
11/28/2007EP1860107A1 Photosensitive compound
11/28/2007EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007EP1860103A1 Anticancer compound, intermediate therefor, and processes for producing these
11/28/2007EP1859811A1 Use of conjugates of amatoxins or phallotoxins with macromolecules for tumor and inflammation therapy
11/28/2007EP1859804A1 Anticancer agent to be combined with telomelysin
11/28/2007EP1859797A1 Novel concomitant use of sulfonamide compound with anti-cancer agent
11/28/2007EP1859796A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
11/28/2007EP1859793A1 Novel combinational use of sulfonamide compound
11/28/2007EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007EP1858913A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
11/28/2007EP1858910A2 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group
11/28/2007EP1858902A1 Bicyclic heteroaromatic derivatives useful as anticancer agents
11/28/2007EP1858898A1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use
11/28/2007EP1858885A1 Indolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858884A1 Indazolylamino quinazoline derivatives as antitumor agents
11/28/2007EP1858883A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/28/2007EP1858882A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
11/28/2007EP1858879A1 1,3-diaryl substituted ureas as modulators of kinase activity
11/28/2007EP1858877A1 1,3 substituted diaryl ureas as modulators of kinase activity
11/28/2007EP1858870A1 Semi-synthetic taxane derivatives with antitumor activity
11/28/2007EP1858860A1 Phthalazinones
11/28/2007EP1858856A2 Cancer treatment using specific 3,6,9-substituted acridines
11/28/2007EP1858836A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/28/2007EP1858539A2 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
11/28/2007EP1858527A1 Oral dosage forms of gemcitabine derivatives
11/28/2007EP1858526A1 Glycoalkaloid and tlr agonist combinations and various uses thereof
11/28/2007EP1858521A2 Compounds and compositions as protein kinase inhbitors
11/28/2007EP1858508A1 Compounds having anti-cancer properties
11/28/2007EP1858507A2 Polyphenol coxib combinations and methods
11/28/2007EP1858355A1 High pressure processing of metal ion lactoferrin
11/28/2007EP1713511A4 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
11/28/2007EP1663978B1 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
11/28/2007EP1597302B1 Polymer guanidine derivatives as a cytostatic medicament
11/28/2007EP1592447B1 Devices and compositions containing boron and silicon for use in neutron capture therapy
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007EP1406613B1 Organic nitratederivatives for the treatment of atherosclerosis and vascular diseases
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1326638B1 Vaccines against cancers
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007EP1293507B1 Process for producing crystal
11/28/2007EP1261322B1 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
11/28/2007EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007EP0910387B1 Apoptosis associated protein bbk
11/28/2007CN101080499A Genomic screen for epigenetically silenced tumor suppressor genes
11/28/2007CN101080413A Silicon compounds and their use
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080396A Quinoxalines as B Raf inhibitors
11/28/2007CN101080251A Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
11/28/2007CN101080229A Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
11/28/2007CN101080227A Combinations of therapeutic agents for treating cancer
11/28/2007CN101080223A Formulations of suberoylanilide hydroxamic acid and methods for producing same
11/28/2007CN101080222A Chemically stable compositions of 4-hydroxy tamoxifen
11/28/2007CN101078716A Biomarker for response monitoring of CDK inhibitors in the clinic
11/28/2007CN101077887A Human accelerated haematogenous cell proliferated cytokine, preparation method and use thereof
11/28/2007CN101077885A New antitumoral compounds
11/28/2007CN101077884A Modification method for protein or polypeptide antigen, and application thereof
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077865A Phthalazines derivatives, preparation method thereof, medicament composition and use
11/28/2007CN101077418A Bacteria nano magnetosome loaded with primary amino medicine and preparation method thereof
11/28/2007CN101077394A Pill-tablet for treating cancer effectively
11/28/2007CN101077384A Application of traditional Chinese medicine preparation in preparing medicine for treating and preventing gynaecologic disease
11/28/2007CN101077376A Traditional Chinese medicine decoction
11/28/2007CN101077356A Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine and other medicines
11/28/2007CN101077349A Total alkaloids of subprostrate sophora root soft capsules and preparation method and application thereof
11/28/2007CN101077346A Application of N-substituted isatin derivates in preparing anti-tumor medicine
11/28/2007CN101077345A Application of Tagalsin C and its homologous compound in preparing anti-tumor medicine
11/28/2007CN101077335A Anticancer composition containing tyrosine kinase inhibitor
11/28/2007CN101077334A Anticancer composition containing tyrosine kinase inhibitor
11/28/2007CN100351385C Herpes viruses for immune modulation
1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 2211